Evidence map›Paper›PMID 25569266›Full record

ArticleGenes and immunity2015

Genetic association of CD247 (CD3ζ) with SLE in a large-scale multiethnic study.

M Martins, A H Williams, M Comeau, M Marion, J T Ziegler, B I Freedman, J T Merrill, S B Glenn, J A Kelly, K M Sivils and 25 more

Open access · bronzeAbstract read
In one paragraph

Article in Genes and immunity, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Frontiers in veterinary science · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. SLE-Associated Defects Promote Altered T Cell Function.Critical reviews in immunology · 2017
    Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors at 19 institutions in 6 countries.

M Martins1] Instituto de Medicina Molecular, Lisboa, Portugal [2] Instituto Gulbenkian de Ciência, Oeiras, Portugal.ORCID 0000000183606806
A H WilliamsCenter for Public Health Genomics and Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA.
M ComeauCenter for Public Health Genomics and Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA.
M MarionCenter for Public Health Genomics and Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA.
J T ZieglerCenter for Public Health Genomics and Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA.
B I FreedmanSection on Nephrology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.
J T MerrillClinical Pharmacology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
S B GlennClinical Pharmacology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
J A KellyClinical Pharmacology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
K M SivilsArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
J A James1] Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA [2] Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
J M GuthridgeArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
M E Alarcón-Riquelme1] Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA [2] Centro de Genómica e Investigaciones Oncológicas (GENYO), Pfizer-Universidad de Granada-Junta de Andalucía, Granada, Spain.
S-C BaeDepartment of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea.
J-H KimDepartment of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea.
D KimDepartment of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea.
J-M AnayaCenter for Autoimmune Diseases Research (CREA), Universidad del Rosario, Bogota, Colombia.
S A BoackleDivision of Rheumatology, University of Colorado School of Medicine, Aurora, CO, USA.
L A CriswellRosalind Russell Medical Research Center for Arthritis, Department of Medicine, University of California, San Francisco, CA, USA.
R P KimberlyDivision of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
G S AlarcónDivision of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
E E BrownDepartments of Medicine and Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.
L M ViláDivision of Rheumatology, Department of Medicine, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico.
M A PetriDivision of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
R Ramsey-GoldmanDivision of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
T B NiewoldDivision of Rheumatology and Department of Immunology, Mayo Clinic, Rochester, MN, USA.
B P TsaoDivision of Rheumatology, University of California Los Angeles, Los Angeles, CA, USA.
G S GilkesonDivision of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, Charleston, SC, USA.
D L KamenDivision of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, Charleston, SC, USA.
C O JacobDepartment of Medicine, University of Southern California, Los Angeles, CA, USA.
A M StevensCenter for Immunity and Immunotherapies, Seattle Children's Research Institute Arthritis Foundation, Seattle, WA, USA.
P M GaffneyArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
J B Harley1] Division of Rheumatology and the Center for Autoimmune Genomics and Etiology (CAGE), Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA [2] US Department of Veterans Affairs Medical Center, Cincinnati, OH, USA.
C D LangefeldCenter for Public Health Genomics and Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA.
C FeselInstituto Gulbenkian de Ciência, Oeiras, Portugal.
Oklahoma Medical Research Foundation · USWake Forest University · USHanyang University Seoul Hospital · KRUniversity of Alabama at Birmingham · USMedical University of South Carolina · USArthritis Foundation · USCincinnati Children's Hospital Medical Center · USInstituto Gulbenkian de Ciência · PTJohns Hopkins University · USMayo Clinic · USNorthwestern University · USSeattle Children's Hospital · USUniversidad de Granada · ESUniversidad del Rosario · COUniversity of California, Los Angeles · USUniversity of Colorado Denver · USUniversity of Lisbon · PTUniversity of Puerto Rico, Medical Sciences Campus · PRUniversity of Southern California · US

Funding

Engaging University of California Stakeholders for Biorespository ResearchUL1TR000004 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRANDIS, JENNIFER RUBIN · 2012 to 2015
$78.0M
Tracking and Evaluation CoreU54GM104938 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Robert Hal Scofield · 2013 to 2026
$68.2M
Northwestern University Clinical and Translational Science Institute (NUCATS)UL1TR001422 · NCATS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI D'AQUILA, RICHARD · 2015 to 2023
$56.8M
INSTITUTE FOR TRANSLATIONAL HEALTH SCIENCE (UL1): BPCAUL1RR025014 · NCRR · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2007 to 2011
$51.5M
Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
UAB Center for Clinical and Translational Science (CCTS)UL1TR001417 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLY, ROBERT P. · 2015 to 2018
$31.4M
MULTIDISCIPLINARY CLINICAL AND TRANSLATIONAL SCIENCE (MCTS) PROGRAM (UL1)UL1RR025741 · NCRR · NORTHWESTERN UNIVERSITY AT CHICAGO · PI GREENLAND, PHILIP · 2008 to 2011
$24.7M
Colorado Clinical and Translational Science Institute (UL1)UL1TR000154 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2012 to 2013
$20.4M
Re-Engineering Translational Research at the University of ChicagoUL1TR000430 · NCATS · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2012 to 2016
$20.2M
Program Project in the Genetics of SLEP01AR049084 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLY, ROBERT P. · 2002 to 2012
$12.7M
The Interplay of Sociodemographic and Genetic Factors in SLE Health DisparitiesP60AR053308 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KATZ, PATRICIA P · 2006 to 2016
$11.8M
SOUTH CAROLINA CLINICAL & TRANSLATIONAL RESEARCH INSTITUTE (SCTR)UL1RR029882 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2009 to 2011
$10.1M
NCATS NIH HHS UL1 TR000004NCATS NIH HHS UL1TR000004NCATS NIH HHS UL1 TR000154NCATS NIH HHS UL1 TR000165NCATS NIH HHS UL1TR000165NCATS NIH HHS UL1 TR000430NCATS NIH HHS UL1 TR001082NCATS NIH HHS UL1 TR001417NCATS NIH HHS UL1 TR001422NCRR NIH HHS UL1 RR025014NCRR NIH HHS UL1RR025014NCRR NIH HHS UL1 RR025741NCRR NIH HHS UL1RR025741NCRR NIH HHS UL1 RR029882NCRR NIH HHS UL1RR029882NIAID NIH HHS AI083194NIAID NIH HHS K24 AI078004NIAID NIH HHS P01 AI083194NIAID NIH HHS P01AI083194NIAID NIH HHS R01 AI063274NIAID NIH HHS R21 AI070304NIAID NIH HHS R21AI070304NIAID NIH HHS R37 AI024717NIAID NIH HHS R37AI024717NIAID NIH HHS R56 AI063274NIAID NIH HHS U01 AI101934NIAID NIH HHS U01AI101934NIAID NIH HHS U19 AI082714NIAID NIH HHS U19AI082714NIAMS NIH HHS AR056360NIAMS NIH HHS AR43727NIAMS NIH HHS K24 AR002138NIAMS NIH HHS K24AR002138NIAMS NIH HHS P01 AR049084NIAMS NIH HHS P01AR049084NIAMS NIH HHS P01AR49084NIAMS NIH HHS P30 AR053483NIAMS NIH HHS P30AR53483NIAMS NIH HHS P602AR30692NIAMS NIH HHS P60 AR030692NIAMS NIH HHS P60 AR053308NIAMS NIH HHS P60AR053308NIAMS NIH HHS P60 AR062755NIAMS NIH HHS P60AR062755NIAMS NIH HHS R01 AR043727NIAMS NIH HHS R01 AR043814NIAMS NIH HHS R01 AR051545NIAMS NIH HHS R01AR051545-03NIAMS NIH HHS R01 AR056360NIAMS NIH HHS R01 AR057172NIAMS NIH HHS R01AR057172NIAMS NIH HHS R01 AR064820NIAMS NIH HHS R01AR43814NIGMS NIH HHS P30 GM103510NIGMS NIH HHS P30GM103510NIGMS NIH HHS U54 GM104938PHS HHS P01083194
6 · The paper itself

Abstract

A classic T-cell phenotype in systemic lupus erythematosus (SLE) is the downregulation and replacement of the CD3ζ chain that alters T-cell receptor signaling. However, genetic associations with SLE in the human CD247 locus that encodes CD3ζ are not well established and require replication in independent cohorts. Our aim was therefore to examine, localize and validate CD247-SLE association in a large multiethnic population. We typed 44 contiguous CD247 single-nucleotide polymorphisms (SNPs) in 8922 SLE patients and 8077 controls from four ethnically distinct populations. The strongest associations were found in the Asian population (11 SNPs in intron 1, 4.99 × 10(-4) < P < 4.15 × 10(-2)), where we further identified a five-marker haplotype (rs12141731-rs2949655-rs16859085-rs12144621-rs858554; G-G-A-G-A; P(hap) = 2.12 × 10(-5)) that exceeded the most associated single SNP rs858554 (minor allele frequency in controls = 13%; P = 4.99 × 10(-4), odds ratio = 1.32) in significance. Imputation and subsequent association analysis showed evidence of association (P < 0.05) at 27 additional SNPs within intron 1. Cross-ethnic meta-analysis, assuming an additive genetic model adjusted for population proportions, showed five SNPs with significant P-values (1.40 × 10(-3) < P< 3.97 × 10(-2)), with one (rs704848) remaining significant after Bonferroni correction (P(meta) = 2.66 × 10(-2)). Our study independently confirms and extends the association of SLE with CD247, which is shared by various autoimmune disorders and supports a common T-cell-mediated mechanism.

Indexed as

AdultAsian PeopleCase-Control StudiesCD3 ComplexFemaleGenetic Association StudiesGenetic Predisposition to DiseaseHaplotypesHumansLupus Erythematosus, SystemicMalePolymorphism, Single NucleotideT-LymphocytesWhite PeopleCD3 antigen, zeta chainCD3 Complex

Identifiers

PMID25569266
PMCPMC4371129
OpenAlexW2145436352

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.